## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-26T11:12:43.874Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Drug Interaction Checker +" developer_entity: "HYDL" bundle_id: "co.medtap.drugreference" app_store_id: "1313254656" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2020-12-29" report_date: "2026-05-26" last_verified: "2026-05-26" report_version: "14" total_reviews: 66 overall_rating: 4.14 sentiment: "Mixed" sentiment_score: 45 confidence: "low" confidence_score: 0.35 top_praise_theme: "Pharmacists and medical students value the accurate drug interaction checker for clinical reference" top_complaint_theme: "Aggressive paywall implementation prevents access to core interaction features after initial data entry" review_sample_size: 17 total_review_count: 17 analyzed_review_count: 17 data_age_days: 0 momentum_velocity: "zombie" intelligence_version: 3 nemesis: "Drugs.com Medication Guide" competitor_count: 7 tags: ["medical", "subscription", "mixed sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals,", "medical"] canonical_url: "https://marlvel.ai/intel-report/medical/drug-interaction-checker" license: "CC-BY-NC 4.0" content_version: "v2" --- # Drug Interaction Checker + App Audit ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.14 · Sentiment Mixed - **Recent focus**: Aggressive paywall implementation prevents access to core interaction features after initial data entry (top complaint) · Pharmacists and medical students value the accurate drug interaction checker for clinical reference (top praise) > **TL;DR:** Drug Interaction Checker + is a medical app by HYDL, rated 4.14/5 by 66 users, with Mixed user sentiment (45/100), available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Drug Interaction Checker + shows Mixed sentiment (4.14/5 from 66 reviews) — users praise pharmacists and medical students value the accurate drug interaction checker for clinical reference but report issues with aggressive paywall implementation prevents access to core interaction features after initial data entry. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.14/5 (66 reviews) | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | HYDL | | **Pricing** | Subscription | | **Platforms** | iOS | | **Confidence** | Low (0.35/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** HYDL - **Category:** Medical - **Target Audience:** Healthcare professionals, medical students, and patients requiring verified pharmacological reference data. - **Platforms:** iOS - **Version Audited:** 14 - **Audit Date:** 2026-05-26 - **Signal Count:** 17 reviews analyzed - **Confidence:** Low (0.35/1.0) - **App Store ID (iOS):** 1313254656 - **Bundle ID:** co.medtap.drugreference - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-05-26 ## Executive Snapshot **What it is:** Drug Interaction Checker + is a mobile medical reference tool providing pharmacological data, pill identification, and interaction checking for healthcare professionals and patients. **Why users hire it:** Users hire this app for rapid, verified clinical decision support that fits into a mobile workflow, replacing bulky desktop references. ## App DNA (Features & Intent) - **[Differentiator] Drug Interaction Checker:** Cross-references a user-input list of medications to identify potential adverse events or efficacy issues - **[Differentiator] Pill Identifier:** Matches pill images and physical characteristics like imprint, shape, and color to specific drug names - **[Standard] Drug Monographs:** Provides detailed pharmacology, dosage, contraindications, and clinical trial results for individual drugs * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} The app maintains niche grossing positions in international markets (e.g., #49 in RO), but high rank volatility suggests the current subscription-gated model struggles to sustain long-term user retention. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free tier with limited access, Premium subscription at $9.99/month or $49.99/year - **Analysis:** Subscription model anchored at $9.99/month, gating core clinical tools behind a paywall. ## 🟡 User Sentiment (Low Confidence: 17 of 17 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.14/5 - **Platform Split:** iOS 4.1/5 (66 ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Pharmacists and medical students value the accurate drug interaction checker for clinical reference** - **Quick navigation and diverse search options facilitate efficient drug information retrieval for users** ### Top Complaints (Impact Areas) - **Aggressive paywall implementation prevents access to core interaction features after initial data entry** - **Subscription management and cancellation processes are opaque and difficult to navigate post-update** ## SWOT Analysis {#swot} **Core Strengths:** - High-accuracy interaction checker provides reliable clinical utility - Lightweight interface enables faster lookups than encyclopedic rivals **Critical Frictions:** - Aggressive paywalling post-data entry drives negative sentiment - Opaque subscription cancellation process increases churn - Incomplete herbal remedy database limits utility **Growth Levers:** - Expand database to include herbal remedies to capture wellness audience - Implement limited free-tier interaction check to improve conversion **Market Threats:** - Drugs.com's free, comprehensive database model - Increasing user sensitivity to subscription-gated medical information - Volatility in international grossing ranks ## Recent Changes (v2 → v3) {#recent-changes} The analysis transitioned from a high-level maintenance assessment to a granular critique of the app's conversion funnel, identifying aggressive paywalling as the primary driver of user churn. **Overall trend**: Declining **Compared at**: 2026-05-26 ### High-impact changes - **[Added] User Sentiment Data** (sentiment) — Sentiment analysis is now available (17 reviews, 4.13 rating), identifying aggressive paywalling and opaque cancellation processes as top complaints. - **[Added] Competitive Landscape** (positioning) — Added formal competitive analysis identifying Drugs.com as the primary nemesis, emphasizing the threat of free-to-access medical databases. ### Medium-impact changes - **[Added] New Weaknesses and Threats** (swot) — Added weaknesses for opaque subscription cancellation and missing herbal remedy data; added threats regarding user sensitivity to paywalled medical information. - **[Shifted] Strategic Focus** (positioning) — PM action items shifted from general database modernization to a specific pivot toward a limited free-tier interaction check to fix conversion. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Drug Interaction Checker + vs Drugs.com Medication Guide — Head to Head - **[Drugs.com Medication Guide](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide)** by Drugs.com: This is the definitive market leader for drug reference and interaction checking, maintaining a massive, authoritative database that serves as the industry standard. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Maintains a comprehensive, professionally curated drug database that is widely considered the gold standard for accuracy. - Integrates advanced pill identification tools directly into the core medication guide experience for seamless cross-referencing. - Provides deep clinical pharmacology data that exceeds the basic summary information found in smaller reference tools. - **Where Drug Interaction Checker + wins:** - ✅ Offers a more focused, lightweight interface that prioritizes quick interaction checks over the dense, encyclopedic content of the rival. - **Where Drugs.com Medication Guide wins:** - ❌ Leverages a massive, trusted brand authority that drives high user retention and consistent, long-term platform engagement. - ❌ Provides a more robust, multi-platform ecosystem that includes advanced pill identification and extensive clinical monographs. - **Verdict:** The target app must pivot toward a specialized, high-speed UX to differentiate from the encyclopedic, data-heavy dominance of the Drugs.com platform. ### Contenders (Strong Challengers) - **[Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe)** by MediSafe Inc. [Moat: High]: Dominates the medication adherence space with a massive user base and high-frequency release cadence. - Focuses on behavioral adherence through personalized reminders and family-sharing features rather than just static drug reference data. - Implements a high-frequency update cycle that keeps the app relevant with modern OS features and user engagement loops. - **[GoodRx: Prescription Savings](https://marlvel.ai/intel-report/medical/com-goodrx-iphone)** by GoodRx [Moat: High]: Captures the financial utility segment of the medical market with massive scale and aggressive feature shipping. - Integrates real-time pharmacy pricing and coupon generation, creating a transactional utility that drives daily active usage. - Maintains an aggressive release schedule, shipping frequent updates to optimize the user's path to prescription savings. - **[AMBOSS Medical Knowledge](https://marlvel.ai/intel-report/medical/us-miamed-amboss-knowledge)** by AMBOSS [Moat: Medium]: Targets the professional medical student and physician demographic with high-fidelity, peer-reviewed clinical content. - Provides a highly structured, exam-focused knowledge base designed specifically for medical education and clinical decision support. - Features a sophisticated, cross-referenced content architecture that allows users to navigate complex medical topics with high precision. ### Peers (What They Do Better) - **[WebMD: Symptom Checker](https://marlvel.ai/intel-report/medical/webmd-symptom-checker)** by WebMD: A broad-spectrum medical resource that captures the general consumer audience through symptom-based search intent. - Utilizes a symptom-checker engine to drive top-of-funnel traffic, which is a different entry point than a direct drug reference tool. - Offers a massive library of general health content that keeps users within the ecosystem for non-medication-related queries. - **[Medscape](https://marlvel.ai/intel-report/medical/medscape)** by WebMD: A professional-grade medical reference tool that serves as a direct alternative for clinical drug information. - Provides clinical news and continuing medical education (CME) credits, catering specifically to the professional healthcare provider audience. - Includes a robust clinical calculator suite that adds significant utility beyond simple drug interaction checking. ### New Kids on the Block (What's Innovative) - **[Full Code Medical Simulation](https://marlvel.ai/intel-report/medical/com-minerva-medical-fullcode)** by Full Code Medical Inc.: An emerging threat in the medical education space, focusing on gamified clinical simulation rather than static reference. ## What's New - **Latest (v14, 5 years ago):** Performed a database update. ## App Momentum (Zombie) {#momentum} - Ships database updates for clinical accuracy. - Maintains niche international grossing presence. > **Cadence:** 1 total versions · 0 majors in last 6 months · 1973 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Drug Interaction Checker + is an established medical app that is available. With a 4.14/5 rating from 66 reviews, it shows polarized user reception. > **Bottom Line:** The app provides high-accuracy clinical data that professionals value, but the aggressive paywalling of core features drives significant user frustration, so the PM should pivot to a more transparent freemium model to stabilize retention. **Best for:** Healthcare professionals, medical students, and patients requiring verified pharmacological reference data. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Implement a limited free-tier interaction check because paywalling post-data entry is the #1 complaint → increase conversion trust. — *Sentiment analysis identifies aggressive paywalling as the primary driver of negative reviews.* _(trade-off: deprioritize Pause the database expansion for herbal remedies — fixing the conversion funnel is a higher revenue priority.)_ - [ ] [MAINTAIN] [MEDIUM IMPACT] Audit subscription management links because users report difficulty canceling trials → reduce churn and support overhead. — *User complaints highlight opaque cancellation processes as a major frustration point.* _(trade-off: deprioritize Same-quarter capacity available — no major lever displaced.)_ ### Feature Gaps vs Competitors - Comprehensive herbal remedy database (available in Drugs.com but missing here) - Clinical calculator suite (available in Medscape but missing here) ### Outlook: Declining The medical reference market is consolidating around free, comprehensive databases, leaving niche apps with restrictive paywalls exposed to high churn. The subject app must pivot its monetization strategy to prioritize user trust over immediate conversion to avoid further rank erosion. - 🔴 Aggressive paywalling post-data entry triggers high-frequency churn complaints, which erodes the long-term user base and damages brand reputation. - 🔴 The lack of herbal remedy data creates a functional gap that limits the app's utility for comprehensive medication reviews. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.14/5 | | Total Reviews | 66 | | Sentiment | Mixed (45/100) | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Drug Interaction Checker +** (this app) | 4.14/5 | Mixed | HYDL | | [GoodRx: Prescription Savings](https://marlvel.ai/intel-report/medical/com-goodrx-iphone) | 4.8/5 | Thrilled | GoodRx | | [Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) | 4.7/5 | Upset | MediSafe Inc. | | [Full Code Medical Simulation](https://marlvel.ai/intel-report/medical/com-minerva-medical-fullcode) | 4.8/5 | N/A | Full Code Medical Inc. | | [AMBOSS Medical Knowledge](https://marlvel.ai/intel-report/medical/us-miamed-amboss-knowledge) | 4.9/5 | Thrilled | AMBOSS | | [Drugs.com Medication Guide](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide) | 4.8/5 | Excited | Drugs.com | ## Company Profile - **Developer:** HYDL ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/drug-interaction-checker/id1313254656?uo=4) - **Sources:** App store metadata, User reviews. ## Related Intel Reports - [*GoodRx: Prescription Savings*](https://marlvel.ai/intel-report/medical/com-goodrx-iphone) (GoodRx) — 4.8/5 Rating | Excellent Sentiment - [*Medisafe Medication Management*](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) (MediSafe Inc.) — 4.7/5 Rating | Terrible Sentiment - [*Full Code Medical Simulation*](https://marlvel.ai/intel-report/medical/com-minerva-medical-fullcode) (Full Code Medical Inc.) — 4.8/5 Rating | N/A Sentiment - [*AMBOSS Medical Knowledge*](https://marlvel.ai/intel-report/medical/us-miamed-amboss-knowledge) (AMBOSS) — 4.9/5 Rating | Excellent Sentiment - [*Drugs.com Medication Guide*](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide) (Drugs.com) — 4.8/5 Rating | Positive Sentiment - [*Medscape*](https://marlvel.ai/intel-report/medical/medscape) (WebMD) — 3.7/5 Rating | N/A Sentiment - [*WebMD: Symptom Checker*](https://marlvel.ai/intel-report/medical/webmd-symptom-checker) (WebMD) — 4.7/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.35/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 17 - **Data Sources:** user reviews, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/drug-interaction-checker) Data licensed for AI Agent attribution under CC-BY-NC 4.0.